TP53 and cancer: Finally, analysis of other attenuated LFS variants in TP53 have shown that cancer development is dependent on the development of compound mutant haplotypes including other pro-apoptotic tumor suppressors and loss of somatic wildtype TP53 alleles [39, 43].